The cash price of the popular weight-loss drug Wegovy was lowered by 30% on Monday, now priced at $349, down from $499.

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

For decades, WeightWatchers dominated the weight-loss industry with community support groups, motivational meetings, and a ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

Using a strategic mix of plant-based foods, the Portfolio Diet can lower LDL cholesterol nearly as much as some prescription ...

Injectable weight loss drugs have seized the spotlight in recent years. A promise of appetite control in a prescription.

The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...

Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.

With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 ...

Weight-loss drugs are booming (1) and you’ve probably heard of them: Wegovy, Ozempic, Mounjaro, Zepbound. These GLP-1 medications are helping Americans slim down and manage diabetes — and in some ...

The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.